Genetics and biology of prostate cancer

G Wang, D Zhao, DJ Spring… - Genes & …, 2018 - genesdev.cshlp.org
Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer
remains largely incurable even after intensive multimodal therapy. The lethality of advanced …

Molecular genetics of prostate cancer: new prospects for old challenges

MM Shen, C Abate-Shen - Genes & development, 2010 - genesdev.cshlp.org
Despite much recent progress, prostate cancer continues to represent a major cause of
cancer-related mortality and morbidity in men. Since early studies on the role of the …

[HTML][HTML] AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox …

TC Chen, JY Chuang, CY Ko, TJ Kao, PY Yang, CH Yu… - Redox biology, 2020 - Elsevier
Drug resistance is the main obstacle in the improvement of chemotherapeutic efficacy in
glioblastoma. Previously, we showed that dehydroepiandrosterone (DHEA), one kind of …

Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis

X Yuan, C Cai, S Chen, Z Yu, SP Balk - Oncogene, 2014 - nature.com
The metabolic functions of androgen receptor (AR) in normal prostate are circumvented in
prostate cancer (PCa) to drive tumor growth, and the AR also can acquire new growth …

Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer

R Vatapalli, V Sagar, Y Rodriguez, JC Zhao… - Nature …, 2020 - nature.com
The histone methyltransferase DOT1L methylates lysine 79 (K79) on histone H3 and is
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …

[HTML][HTML] The molecular and cellular origin of human prostate cancer

JR Packer, NJ Maitland - Biochimica et Biophysica Acta (BBA)-Molecular …, 2016 - Elsevier
Prostate cancer is the most commonly diagnosed male malignancy. Despite compelling
epidemiology, there are no definitive aetiological clues linking development to frequency …

Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants

J An, C Wang, Y Deng, L Yu, H Huang - Cell reports, 2014 - cell.com
The SPOP E3 ubiquitin ligase gene is frequently mutated in human prostate cancers. Here,
we demonstrate that SPOP recognizes a Ser/Thr-rich degron in the hinge domain of …

Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence

I Coutinho, TK Day, WD Tilley… - Endocrine-related …, 2016 - erc.bioscientifica.com
The androgen receptor (AR) signaling axis drives all stages of prostate cancer, including the
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …

Effects of MTX-23, a novel PROTAC of androgen receptor splice variant-7 and androgen receptor, on CRPC resistant to second-line antiandrogen therapy

GT Lee, N Nagaya, J Desantis, K Madura… - Molecular cancer …, 2021 - AACR
Although second-line antiandrogen therapy (SAT) is the standard of care in men with
castration-resistant prostate cancer (CRPC), resistance inevitably occurs. One major …

The androgen receptor in health and disease

T Matsumoto, M Sakari, M Okada… - Annual review of …, 2013 - annualreviews.org
Androgens play pivotal roles in the regulation of male development and physiological
processes, particularly in the male reproductive system. Most biological effects of androgens …